|
57
|
204
|
5l54I |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
71
|
240
|
5l65C |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
69
|
250
|
5laiA |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
63
|
231
|
5l52E |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
69
|
243
|
5l5zF |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
67
|
242
|
5l5vD |
'yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
69
|
228
|
5lajM |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
56
|
204
|
5lf3I |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
62
|
211
|
5l5oK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
68
|
233
|
5l69M |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
70
|
233
|
5laiM |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
61
|
234
|
5lf1E |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
58
|
204
|
5l5oI |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
67
|
242
|
5l5zD |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
65
|
231
|
5l68E |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
63
|
231
|
5lttE |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
90
|
294
|
4yskA |
Crystal structure of apo-form sdoa from pseudomonas putida |
|
103
|
378
|
5jzdA |
A re-refinement of the isochorismate synthase entc |
|
72
|
243
|
5jhrF |
Yeast 20s proteasome in complex with the peptidic epoxyketone inhibitor 27 |
|
37
|
198
|
5a0qM |
Cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core |
|
178
|
540
|
5khaA |
Structure of glutamine-dependent nad+ synthetase from acinetobacter baumannii in complex with adenosine diphosphate (adp) |
|
70
|
228
|
5k4kA |
Directed evolutionary changes in mbl super family - ndm-1 round 10 crystal-4 |
|
65
|
242
|
5jhsD |
Yeast 20s proteasome in complex with the peptidic epoxyketone inhibitor 15 |
|
78
|
249
|
5j3zA |
Crystal structure of m2htdp2-cat in complex with a small molecule inhibitor |
|
75
|
228
|
5k4nA |
Directed evolutionary changes in mbl super family - ndm-1 round 10 crystal-2 |
|
65
|
241
|
5jhrG |
Yeast 20s proteasome in complex with the peptidic epoxyketone inhibitor 27 |
|
81
|
291
|
5j92A |
Crystal structure of a putative alpha-ketoglutarate dependent 2,4-d dioxygenase from burkholderia xenovorans |
|
44
|
197
|
5a0qN |
Cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core |
|
102
|
294
|
4yslA |
Crystal structure of sdoa from pseudomonas putida in complex with glutathione |
|
73
|
228
|
5k4mA |
Directed evolutionary changes in mbl super family - ndm-1 round 10 crystal-3 |
|
70
|
233
|
5jhrM |
Yeast 20s proteasome in complex with the peptidic epoxyketone inhibitor 27 |
|
67
|
229
|
4z1lM |
Yeast 20s proteasome in complex with belactosin c derivative 3 |
|
59
|
196
|
5bouN |
Yeast 20s proteasome in complex with a beta1 / beta2 specific non-peptidic sulfonamide ligand |
|
50
|
174
|
5ji2A |
Hslu l199q in hsluv complex |
|
56
|
248
|
5j3sA |
Crystal structure of the catalytic domain of human tyrosyl dna phosphodiesterase 2 in complex with a small molecule inhibitor |
|
104
|
301
|
5hioA |
Crystal structure of pqs response protein pqse in complex with 2-aminobenzoylacetate |
|
98
|
297
|
5h8kA |
Crystal structure of medicago truncatula n-carbamoylputrescine amidohydrolase (mtcpa) c158s mutant |
|
87
|
266
|
5hh5A |
Crystal structure of b3 metallo-beta-lactamase l1 complexed with a phosphonate-based inhibitor |
|
27
|
187
|
5hftB |
Crystal structure of hpxw |
|
101
|
298
|
5hipA |
Crystal structure of pqs response protein pqse in complex with 2-(pyridin-3-yl)benzoic acid |
|
85
|
266
|
5hh6A |
Crystal structure of b3 metallo-beta-lactamase l1 in complex with a phosphonate-based inhibitor |
|
93
|
297
|
5h8lA |
Crystal structure of medicago truncatula n-carbamoylputrescine amidohydrolase (mtcpa) c158s mutant in complex with putrescine |
|
43
|
189
|
5a0qK |
Cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core |
|
93
|
321
|
5hkeA |
Bile salt hydrolase from lactobacillus salivarius |
|
79
|
248
|
5inmA |
Mouse tdp2 protein, apo state with variable dna-binding grasp conformations |
|
60
|
243
|
5a0qC |
Cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core |
|
100
|
298
|
5h8iA |
Crystal structure of medicago truncatula n-carbamoylputrescine amidohydrolase (mtcpa) in complex with n-(dihydroxymethyl)putrescine |
|
69
|
217
|
5b3rA |
Crystal structure of metallo-beta-lactamase imp-18 from pseudomonas aeruginosa |
|
61
|
218
|
5hh4A |
Crystal structure of metallo-beta-lactamase imp-1 in complex with a phosphonate-based inhibitor |
|
98
|
296
|
5h8jA |
Crystal structure of medicago truncatula n-carbamoylputrescine amidohydrolase (mtcpa) in complex with cadaverine |
